COAGULATION
sthemO: in summary n Greater productivity: the analyser never stops working;
n XXL loading capacity and new packaging for optimum walkaway capabilities;
n Up to 156 product vials onboard for sthemO 301;
n High throughput for all test combinations.
One cuvette. One test. Four embedded technologies While its creators are keen to emphasise the simplicity and intuitiveness of their sthemO analysers, there is some cutting- edge innovation to be found under the hood.
sthemO’s ‘revolutionary analytical core’ sthemO revolutionary new cuvettes enable four technologies in one cuvette.
sthemO: maximum autonomy for more productivity Thanks to a breakthrough in haemostasis technology, scientists can let sthemO – Stago’s next-generation haemostasis analyser – automatically handle the peaks in their coagulation laboratory activity, through continuous loading and unloading of samples, reagents and consumables without interrupting the analytical cycle. Its onboard storage capacity gives scientists maximum walkaway capabilities, freeing valuable time for critical or complex tasks that require more attention. For a workforce where competences must often be demonstrated across multiple disciplines, laboratory staff will be delighted to discover sthemO’s efficient and intuitive user interface keeps things simple, limiting the amount of training required. Likewise, routine processes, such as changing consumables, are accompanied by easy-to-follow instructions and graphics. Meanwhile, the QR code on each reagent vial offers complete traceability, acting as a unique identifier that greatly facilitates reagent unloading and reloading across platforms, alongside a continuous loading rack- based system which further maximises productivity.
Integrated smart features are designed to make daily life even easier, while enhancing sthemO’s efficiency. An onboard camera and embedded artificial intelligence recognises and automatically processes different sample tube types, while the onboard stirring system limits reagent handling, removing the need for stir bars and reducing the risk of manual errors.
16 “sthemO doesn’t just deliver faster
results,” says Yannig Querel, Business Unit Marketing Manager – UK at Stago. “Its new line of dedicated reagents offers optimal performances and a wider range of tests – delivering enhanced accuracy, reliability and consistency of test results, and ultimately improved patient management.” For scalability, Stago offers two variations of sthemO – the flagship 301 model, for high-activity laboratories, and the 201, a compact benchtop version designed for small to medium laboratories, which offers the same efficiency and analytical performance.
– a breakthrough which includes Stago’s exclusive ‘VBDS Plus’ technology – performs optical measurements in parallel to its gold standard viscosity-based detection system (VBDS), all in the same cuvette.1
Running clotting tests using
VBDS and three different wavelengths in parallel not only increases productivity, but also opens up opportunities for new clinical applications.
Four embedded technologies n VBDS Plus n Colorimetry n Turbidimetry n Immunochemiluminescence sthemO’s analytical core also includes integrated immunochemiluminescence (reagents under development) technology, delivering optimal performance with new parameters – and increasing throughput of all test
The newly developed graphical user interface is common across all sthemO instruments and the new sthemE Manager.
SEPTEMBER 2024
WWW.PATHOLOGYINPRACTICE.COM
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56
